These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28238947)

  • 21. Evaluating the Role of Multidrug Resistance Protein 3 (MDR3) Inhibition in Predicting Drug-Induced Liver Injury Using 125 Pharmaceuticals.
    Aleo MD; Shah F; He K; Bonin PD; Rodrigues AD
    Chem Res Toxicol; 2017 May; 30(5):1219-1229. PubMed ID: 28437613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transporter-Mediated Disposition, Clinical Pharmacokinetics and Cholestatic Potential of Glyburide and Its Primary Active Metabolites.
    Li R; Bi YA; Vildhede A; Scialis RJ; Mathialagan S; Yang X; Marroquin LD; Lin J; Varma MVS
    Drug Metab Dispos; 2017 Jul; 45(7):737-747. PubMed ID: 28438781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new mechanism for increasing the oral bioavailability of scutellarin with Cremophor EL: Activation of MRP3 with concurrent inhibition of MRP2 and BCRP.
    Xiao L; Yi T; Chen M; Lam CW; Zhou H
    Eur J Pharm Sci; 2016 Oct; 93():456-67. PubMed ID: 27586020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction of triple-transfected cells [organic anion-transporting polypeptide (OATP) 1B1/multidrug resistance-associated protein (MRP) 2/MRP3 and OATP1B1/MRP2/MRP4] for analysis of the sinusoidal function of MRP3 and MRP4.
    Hirouchi M; Kusuhara H; Onuki R; Ogilvie BW; Parkinson A; Sugiyama Y
    Drug Metab Dispos; 2009 Oct; 37(10):2103-11. PubMed ID: 19628752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the role of polar amino acid residues within predicted transmembrane helix 17 in determining the substrate specificity of multidrug resistance protein 3.
    Zhang DW; Gu HM; Vasa M; Muredda M; Cole SP; Deeley RG
    Biochemistry; 2003 Aug; 42(33):9989-10000. PubMed ID: 12924948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alteration of the expression of adenosine triphosphate-binding cassette transporters associated with bile acid and cholesterol transport in the rat liver and intestine during cholestasis.
    Kamisako T; Ogawa H
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1429-34. PubMed ID: 16105132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estradiol 3-glucuronide is transported by the multidrug resistance-associated protein 2 but does not activate the allosteric site bound by estradiol 17-glucuronide.
    Gerk PM; Li W; Vore M
    Drug Metab Dispos; 2004 Oct; 32(10):1139-45. PubMed ID: 15280218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of hepatic transporters in the disposition and hepatotoxicity of a HER2 tyrosine kinase inhibitor CP-724,714.
    Feng B; Xu JJ; Bi YA; Mireles R; Davidson R; Duignan DB; Campbell S; Kostrubsky VE; Dunn MC; Smith AR; Wang HF
    Toxicol Sci; 2009 Apr; 108(2):492-500. PubMed ID: 19223659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time-course activities of Oct1, Mrp3, and cytochrome P450s in cultures of cryopreserved rat hepatocytes.
    Jacobsen JK; Jensen B; Skonberg C; Hansen SH; Badolo L
    Eur J Pharm Sci; 2011 Oct; 44(3):427-36. PubMed ID: 21925601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes.
    Hartman JC; Brouwer K; Mandagere A; Melvin L; Gorczynski R
    Can J Physiol Pharmacol; 2010 Jun; 88(6):682-91. PubMed ID: 20628435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutational analysis of a highly conserved proline residue in MRP1, MRP2, and MRP3 reveals a partially conserved function.
    Létourneau IJ; Slot AJ; Deeley RG; Cole SP
    Drug Metab Dispos; 2007 Aug; 35(8):1372-9. PubMed ID: 17494643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fasiglifam (TAK-875): Mechanistic Investigation and Retrospective Identification of Hazards for Drug Induced Liver Injury.
    Otieno MA; Snoeys J; Lam W; Ghosh A; Player MR; Pocai A; Salter R; Simic D; Skaggs H; Singh B; Lim HK
    Toxicol Sci; 2018 Jun; 163(2):374-384. PubMed ID: 28206647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interplay of phase II enzymes and transporters in futile cycling: influence of multidrug resistance-associated protein 2-mediated excretion of estradiol 17beta-D-glucuronide and its 3-sulfate metabolite on net sulfation in perfused TR(-) and Wistar rat liver preparations.
    Sun H; Zeng YY; Pang KS
    Drug Metab Dispos; 2010 May; 38(5):769-80. PubMed ID: 20124397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides.
    Zelcer N; van de Wetering K; de Waart R; Scheffer GL; Marschall HU; Wielinga PR; Kuil A; Kunne C; Smith A; van der Valk M; Wijnholds J; Elferink RO; Borst P
    J Hepatol; 2006 Apr; 44(4):768-75. PubMed ID: 16225954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabinoid type 1 receptor antagonists modulate transport activity of multidrug resistance-associated proteins MRP1, MRP2, MRP3, and MRP4.
    Wittgen HG; van den Heuvel JJ; van den Broek PH; Dinter-Heidorn H; Koenderink JB; Russel FG
    Drug Metab Dispos; 2011 Jul; 39(7):1294-302. PubMed ID: 21511945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and functional characterization of the natural variant MRP3-Arg1297His of human multidrug resistance protein 3 (MRP3/ABCC3).
    Lee YM; Cui Y; König J; Risch A; Jäger B; Drings P; Bartsch H; Keppler D; Nies AT
    Pharmacogenetics; 2004 Apr; 14(4):213-23. PubMed ID: 15083066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane.
    König J; Rost D; Cui Y; Keppler D
    Hepatology; 1999 Apr; 29(4):1156-63. PubMed ID: 10094960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting Inhibitors for Multidrug Resistance Associated Protein-2 Transporter by Machine Learning Approach.
    Kharangarh S; Sandhu H; Tangadpalliwar S; Garg P
    Comb Chem High Throughput Screen; 2018; 21(8):557-566. PubMed ID: 30360705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The vesicular transport assay: validated in vitro methods to study drug-mediated inhibition of canalicular efflux transporters ABCB11/BSEP and ABCC2/MRP2.
    Herédi-Szabó K; Kis E; Krajcsi P
    Curr Protoc Toxicol; 2012 Nov; Chapter 23():Unit 23.4. PubMed ID: 23169269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional characterization of multidrug resistance-associated protein 3 (mrp3/abcc3) in the basolateral efflux of glucuronide conjugates in the mouse small intestine.
    Kitamura Y; Kusuhara H; Sugiyama Y
    J Pharmacol Exp Ther; 2010 Feb; 332(2):659-66. PubMed ID: 19889793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.